Unknown

Dataset Information

0

Shared Molecular Targets Confer Resistance over Short and Long Evolutionary Timescales.


ABSTRACT: Pre-existing and de novo genetic variants can both drive adaptation to environmental changes, but their relative contributions and interplay remain poorly understood. Here we investigated the evolutionary dynamics in drug-treated yeast populations with different levels of pre-existing variation by experimental evolution coupled with time-resolved sequencing and phenotyping. We found a doubling of pre-existing variation alone boosts the adaptation by 64.1% and 51.5% in hydroxyurea and rapamycin, respectively. The causative pre-existing and de novo variants were selected on shared targets: RNR4 in hydroxyurea and TOR1, TOR2 in rapamycin. Interestingly, the pre-existing and de novo TOR variants map to different functional domains and act via distinct mechanisms. The pre-existing TOR variants from two domesticated strains exhibited opposite rapamycin resistance effects, reflecting lineage-specific functional divergence. This study provides a dynamic view on how pre-existing and de novo variants interactively drive adaptation and deepens our understanding of clonally evolving populations.

SUBMITTER: Li J 

PROVIDER: S-EPMC6445301 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Shared Molecular Targets Confer Resistance over Short and Long Evolutionary Timescales.

Li Jing J   Vázquez-García Ignacio I   Persson Karl K   González Asier A   Yue Jia-Xing JX   Barré Benjamin B   Hall Michael N MN   Long Anthony A   Warringer Jonas J   Mustonen Ville V   Liti Gianni G  

Molecular biology and evolution 20190401 4


Pre-existing and de novo genetic variants can both drive adaptation to environmental changes, but their relative contributions and interplay remain poorly understood. Here we investigated the evolutionary dynamics in drug-treated yeast populations with different levels of pre-existing variation by experimental evolution coupled with time-resolved sequencing and phenotyping. We found a doubling of pre-existing variation alone boosts the adaptation by 64.1% and 51.5% in hydroxyurea and rapamycin,  ...[more]

Similar Datasets

| S-EPMC2867753 | biostudies-literature
| S-EPMC6054916 | biostudies-literature
| S-EPMC5067116 | biostudies-literature
| S-EPMC3517908 | biostudies-literature
| S-EPMC5570091 | biostudies-literature
| S-EPMC10716100 | biostudies-literature
| S-EPMC5112998 | biostudies-literature
| S-EPMC6722887 | biostudies-other
| S-EPMC4920342 | biostudies-literature
| S-EPMC6369792 | biostudies-literature